Skip to main content
TipRanks
Go Ultimate75% OFF

Trimas (TRS) Q3 2026 Earnings Report

138 Followers

TRS Q3 2026 EPS Results

Actual EPS
$0.50
Consensus EPS
$0.48
Beat/Miss
Beat by +$0.02
One Year Ago EPS
$0.61

TRS Q3 2026 Revenue Results

Actual Revenue
$178.74M
Expected Revenue
$175.16M
Beat/Miss
Beat by +$3.58M
YoY Revenue Growth
-33.62%

Earnings Announcement Details

Quarter
Q3 2026
Date
10/29/2026
Time
Before Open
Conference Call
Thursday, October 29, 2026
TRS Upcoming Earnings

Trimas's next earnings date is estimated for March 4, 2027, based on past reporting schedules.

Q3 2026 Earnings Call Audio

TRS Q3 2026 Earnings Call
0:00 / 0:00

Q3 2026 Earnings Slide Deck

Q3 2026 Earnings Call Summary

Q3 2026
Earnings Call Date:Oct 29, 2026|% Change Since:-4.07%|
Earnings Call Sentiment|Positive

The call was predominantly positive, with strong third-quarter and year-to-date revenue, operating profit, earnings, Packaging performance, cost-reduction progress, share repurchases, liquidity, and reaffirmed full-year guidance. The main challenges were the ongoing Norris Cylinder throughput and productivity issues, reduced Specialty Products margin expectations, delayed Packaging price-cost recovery, seasonal fourth-quarter softness, and the absence of a completed acquisition announcement.

Company Guidance

TriMas reaffirmed its adjusted earnings per share outlook of $1.60-$1.70, expects Packaging and Specialty Products to collectively deliver 4%-6% year-over-year sales growth, and continues to expect operating profit margin expansion of 250 basis points for the year; Packaging’s full-year sales outlook is 4%-5% sales growth and full-year operating profit margin of nearly 14%, with fourth quarter sales expected to moderate sequentially while both sales and operating margins are expected to improve compared to the prior year period; Specialty Products is expected to deliver full-year sales growth of 7%-10% and full-year operating profit margins in the range of 4%-6%; fourth quarter sales, earnings, and earnings per share are expected to improve year-over-year, while the fourth quarter is typically our seasonally weakest period, and fourth quarter should be by far the best free cash flow generation quarter of the year; previously announced cost reduction actions totaling $10.5 million in expected 2026 savings and $16 million on an annualized basis remain on track, and Rapak contributed approximately $20 million of annual sales.

  • Strong Third-Quarter Revenue and Earnings GrowthThird-quarter net sales increased 7.7% to $178.7 million, including 7.2% organic growth supported by growth across all major end markets served by Packaging and Specialty Products. Operating profit increased 47.9% to $13.6 million, operating profit margin expanded 200 basis points to 7.6%, and adjusted earnings per share increased to $0.50 from $0.17 in the prior-year period.
  • Solid Year-to-Date PerformanceThrough the first nine months of 2026, net sales increased 6.4% to $521.6 million, operating profit increased 35.8% to $41.2 million, and earnings per share more than doubled to $1.25. The company attributed the results to organic growth, disciplined execution of cost actions, and higher interest income on Aerospace proceeds.
  • Cost Reduction Program on TrackThe previously announced cost reduction actions totaling $10.5 million in expected 2026 savings and $16 million on an annualized basis are proceeding as planned and are contributing to year-over-year profit improvement.
  • Packaging Delivers Broad-Based GrowthThird-quarter Packaging net sales increased 8.8% to $148 million, including approximately 8.2% organic growth, driven by higher demand across beauty and personal care, food and beverage, life sciences, and industrial applications. Packaging operating profit increased 11.9% to $20.4 million, while operating margin expanded 40 basis points to 13.8%, reflecting higher volumes, productivity improvements, and cost reduction initiatives.
  • Packaging Outlook Remains FavorableThe company expects full-year Packaging sales growth of 4%-5% and now expects full-year operating profit margin of nearly 14%. Fourth-quarter sales and operating margins are expected to improve compared with the prior-year period, despite normal seasonal moderation in sales.
  • Specialty Products Demand and Market Share GainsSpecialty Products third-quarter net sales increased 2.7% year-over-year to approximately $31 million, driven by continued market share gains and solid customer demand at Norris Cylinder. Year-to-date sales increased 9.5% to nearly $92 million.
  • Progress on Norris Cylinder Equipment ReliabilityThe company strengthened Norris Cylinder's operational leadership and implemented actions focused on production planning, scheduling, labor allocation, and order sequencing. Two key machines that experienced significant downtime in the third quarter were operating near expected levels after the quarter, and management said it had better line of sight to improvement.
  • Rapak Divestiture Advances Portfolio FocusTriMas signed an agreement to divest its flexible bag-in-box business, Rapak, to Ringmetall, with closing expected in early November. Management said the transaction will focus the portfolio on key markets and that Rapak has below-average margins; Rapak contributed approximately $20 million of annual sales.
  • Share Repurchases ContinueTriMas repurchased shares during the third quarter, bringing total repurchases since announcing the Aerospace divestiture to more than 5.4 million shares. Year-to-date repurchases reduced shares outstanding by more than 5%, and approximately $67 million remained under the existing authorization at quarter-end. Through the end of the third quarter, the company had spent nearly $184 million on share repurchases.
  • Strong Balance Sheet and LiquidityTriMas ended the third quarter with more than $1.1 billion in cash and approximately $761 million of net cash. The company also has $400 million of 4 1/8% senior notes due in 2029 and no near-term debt maturities, providing flexibility for organic investment, disciplined M&A, and shareholder returns.
  • Improved Free Cash Flow and Investment IncomeThird-quarter free cash flow was nearly $21 million compared with $4 million in the prior-year period, aided by interest and improved quarter-over-quarter working capital. Cash investments generated an average yield of approximately 3.9% during the quarter while maintaining access to capital.
  • Capital Allocation and Growth PrioritiesManagement continues to evaluate acquisition opportunities in life sciences and packaging areas that could strengthen existing platforms or create a more premium portfolio. The company also remains focused on investments supporting organic growth, productivity improvements, innovation, and operational excellence.
  • Reaffirmed Earnings and Revenue OutlookTriMas reaffirmed its adjusted earnings per share outlook of $1.60-$1.70, modestly increased its combined Packaging and Specialty Products sales outlook to 4%-6% year-over-year growth, and continues to expect operating profit margin expansion of 250 basis points for the year. Fourth-quarter sales, earnings, and earnings per share are expected to improve year-over-year.

TRS Earnings History

TRS earnings history
Report DateFiscal QuarterForecast / EPSLast Year's EPSEPS YoY ChangePress Release
Mar 04, 20272026 (Q4)0.41-0.4――
Oct 29, 20262026 (Q3)0.480.500.61-18.03% (-0.11)
Jul 30, 20262026 (Q2)0.490.520.61-14.75% (-0.09)
Apr 30, 20262026 (Q1)0.190.240.46-47.83% (-0.22)
Feb 26, 20262025 (Q4)0.220.400.43-6.98% (-0.03)
Oct 28, 20252025 (Q3)0.560.610.4341.86% (+0.18)
Jul 29, 20252025 (Q2)0.480.610.4341.86% (+0.18)
Apr 29, 20252025 (Q1)0.400.460.3724.32% (+0.09)
Feb 27, 20252024 (Q4)0.480.430.3716.22% (+0.06)
Nov 04, 20242024 (Q3)0.580.430.57-24.56% (-0.14)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat Missed